title: Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits.
abstract: The effects of the administration of coenzyme Q10 (3 mg/kg per day) (group A, n=10) and placebo (aluminum hydroxide, 3 mg/kg per day) (group B, n=10) were compared over 24 weeks in a randomized, single-blind, controlled trial. There were two groups of rabbits receiving a trans fatty acid (TFA)-rich diet (5-8 g/day) for 36 weeks. Oxidized rabbit chow with vitamin C plus ferric chloride was administered for 4 weeks in all rabbits. Intervention with coenzyme Q10 after feeding of TFA-rich diet was associated with a significant decline in thiobarbituric acid reactive substances (TBARS), diene conjugates and malondialdehyde, and an increase in plasma levels of vitamin E in the coenzyme Q group compared to placebo group. These changes, which were indicators of a decrease in oxidative damage, were independent of lipid lowering. The aortic and coronary artery plaque sizes, coronary atherosclerosis index, aortic and coronary atherosclerosis scores were significantly lower in the coenzyme Q group than placebo group. Aortic and coronary plaque frequencies, as well as frequencies of ulceration, thrombosis or hemorrhage, and cracks and fissures, were also significantly lower in the coenzyme Q group, indicating a better quality of atheroma compared to those in the control group. Aortic cholesterol, triglycerides and sudanophilia were significantly lower and vitamin E significantly higher in the coenzyme Q group in comparison to the placebo group indicating that coenzyme Q10 can have beneficial effect on the chemical composition of atheroma. The findings suggest that antioxidant therapy with coenzyme Q10 may be used as an adjunct to lipid lowering for additional beneficial effects related to chemical composition and quality of atheroma independent of hypolipidemic agents.
authors.affiliation: Centre of Nutrition, Medical Hospital and Research Centre, Moradabad, India.
authors.forename: R B
authors.initials: RB
authors.lastname: Singh
authors.forename: S N
authors.initials: SN
authors.lastname: Shinde
authors.forename: R K
authors.initials: RK
authors.lastname: Chopra
authors.forename: M A
authors.initials: MA
authors.lastname: Niaz
authors.forename: A S
authors.initials: AS
authors.lastname: Thakur
authors.forename: Z
authors.initials: Z
authors.lastname: Onouchi
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D003067:Coenzymes; D003331:Coronary Vessels / Q000473:pathology; D011817:Rabbits; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis; D014280:Triglycerides / Q000097:blood; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014810:Vitamin E / Q000097:blood
chemical_list: D000975:Antioxidants; D003067:Coenzymes; D017392:Thiobarbituric Acid Reactive Substances; D014280:Triglycerides; D014451:Ubiquinone; D014810:Vitamin E; D002784:Cholesterol; C024989:coenzyme Q10